Chemical compounds
AssigneeAstraZeneca AB
InventorsHitesh Sanganee, Brian Springthorpe
Life of this patent
Estimating the term…
Abstract
The invention concerns compounds of formula (I), and their use in therapy, particularly in the modulation of CCR3 activity.
Claims19
A compound of formula (I):
- 17
- wherein:
- m and n are, independently, 0, 1, 2, 3 or 4;
- X is CH2, CO, O, S, S(O), S(O)2 or NR6;
- Y is NR4S(O)2R5 or S(O)2NR4R5;
- T is C═O or CR7R8;
- R1 is hydrogen, C1-6 alkyl, aryl or heterocyclyl;
- R2 and R3 are, independently, hydrogen or C1-6 alkyl;
- R4 and R6 are, independently, hydrogen or C1-6 alkyl (optionally substituted with aryl);
- R5 is C1-6 alkyl {optionally substituted by halogen, CO2R11, aryl or heterocyclyl}, C3-10 cycloalkyl {optionally substituted by C1-4 alkyl or oxo}, C3-7 cycloalkenyl {optionally substituted by C1-6 alkyl or aryl}, aryl or heterocyclyl;
- or, when Y is S(O)2NR4R5, R5 may also be hydrogen;
- R7, R8, R9 and R10 are, independently, hydrogen or C1-6 alkyl (optionally substituted with aryl);
- wherein the foregoing aryl and heterocyclyl moieties are, independently, optionally substituted by one or more of halo, cyano, nitro, hydroxy, S(O)qR11, OCONR12R13, NR14R15, NR16COR7, NR18CONR19R20,SO2NR21R22, NR23SO2R24, CONR25R26, COR27, CO2R28, OCOR29, NR30CO2R31, C1-6 alkyl (itself optionally substituted with halo, C1-6 alkoxy, C3-10 cycloalkyl, CO2(C1-6 alkyl), OCO(C1-6 alkyl), SO2R32, CONR33R34, phenyl, phenoxy, heterocyclyl or heterocyclyloxy), C3-10 cycloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C2-6 alkenyl, C2-6 alkynyl, methylenedioxy, phenyl, phenoxy, phenylthio, phenyl(C1-4)alkoxy, heterocyclyl, heterocyclyloxy or heterocyclyl(C1-4)alkoxy;
- wherein any of the immediately foregoing phenyl and heterocyclyl moieties are optionally substituted with halo, hydroxy, nitro, S(O)kC1-4 alkyl, SO2NH2, cyano, C1-4 alkyl, C1-4 alkoxy, CONH2, CONH(C1-4 alkyl), CO2H, CO2(C1-4 alkyl), NHCO(C1-4 alkyl), NHSO2(C1-4 alkyl), CO(C1-4 alkyl), CF3 or OCF3;
- R12, R13, R14, R15, R16, R17, R18, R19, R20, R21, R22, R23, R25, R26, R27, R28, R29, R30, R31, R33 and R34 are, independently, hydrogen, C1-6 alkyl or aryl (itself optionally substituted by halo, C1-6 alkyl, C1-6 haloalkyl, CN, NO2, C1-6 alkoxy or C1-6 haloalkoxy);
- R11, R24 and R32 are, independently, C1-6 alkyl or aryl (itself optionally substituted by halo, C1-6 alkyl, C1-6 haloalkyl, CN, NO2, C1-6 alkoxy or C1-6 haloalkoxy);
- k and q are, independently, 0, 1 or 2;
- or a pharmaceutically acceptable salt thereof;
- or a solvate thereof.
A compound of formula (I) as claimed in any one of the preceding claims wherein X is O.
A compound of formula (I) as claimed in any one of the preceding claims wherein R1 is phenyl substituted with one or more of fluorine, chlorine, C1-4 alkyl or C1-4 alkoxy.
A compound of formula (I) as claimed in any one of the preceding claims wherein R2 and R3 are both hydrogen.
A compound of formula (I) as claimed in any one of the preceding claims wherein R4 is hydrogen or C1-4 alkyl.
A compound of formula (I) as claimed in any one of the preceding claims wherein R9 is hydrogen, C1-4 alkyl or phenyl(C1-4 alkyl).
A compound of formula (I) as claimed in any one of the preceding claims wherein R10 is hydrogen.
A compound of formula (I) as claimed in any one of the preceding claims wherein R5 is C1-6 alkyl {optionally substituted by phenyl (itself optionally substituted by halogen or nitro), CO2(C1-4 alkyl), C3-10 cycloalkyl (itself optionally substituted by oxo or C1-4 alkyl) or heterocyclyl}, aryl {optionally substituted by halogen, C1-6 alky, C1-4 alkoxy, OH, nitro, cyano, CF3, OCF3, N(C1-4 alkyl)2, NHCO(C1-4 alkyl), CO2H or CO2(C1-4 alkyl)} or hererocyclyl {optionally substituted by halogen, oxo, C1-4 alkyl, NHCO(C1-4 alkyl), CO(C1-4 alkyl), CO2H, CO2(C1-4 alkyl), pyridyl or isoxazolyl}.
A compound of formula (I) as claimed in any one of the preceding claims wherein Y is NR4S(O)2R5.
Dependencies are inferred from the claim text.